
















     








A systematic review of the role of heat 
therapy for patients with intermittent 
claudication due to peripheral artery disease
Harwood, A., Pugh, C. J. A., Steward, C., Menzies, C., Thake, C. D. & 
Cullen, T.
Published PDF deposited in Coventry University’s Repository 
Original citation: 
Harwood, A, Pugh, CJA, Steward, C, Menzies, C, Thake, CD & Cullen, T 2021, 'A systematic
review of the role of heat therapy for patients with intermittent claudication due to 






This article is distributed under the terms of the Creative Commons Attribution 4.0 License 
(http://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and 
distribution of the work without further permission provided the original work is 


























A systematic review of the role of heat 1–8 © The Author(s) 2021 
therapy for patients with intermittent Article reuse guidelines:
sagepub.com/journals-permissionsclaudication due to peripheral artery disease DOI: 10.1 77/1358863X209834  
journals.sagepub.com/home/vmj 
Amy E Harwood1 , Christopher JA Pugh2, 
Charles J Steward1, Campbell Menzies1, C Doug Thake1 
and Tom Cullen1 
Abstract 
Intermittent claudication (IC) is associated with impairments in quality of life and walking ability. Heat therapy is an 
emerging cardiovascular therapy, which may improve walking in patients with IC. We undertook a systematic review to 
establish current evidence for heat therapy for patients with IC. We searched five databases (Ovid Medline / PubMed, 
Embase, Scopus / Web of Science, Cochrane Library and Health Technology Assessment Databases). A total of 6751 
records were screened with 76 full-text articles assessed for eligibility. We included three randomised control trials 
and three acute interventions. For chronic interventions, three different heat therapy interventions were used. The 
6-minute walk distance significantly improved following whole-body immersion (p = 0.03; ES 0.94, 95% CI: 0.06–1.82), 
but not after Waon therapy or a water-perfused garment. Ankle–brachial pressure indices were significantly improved 
following whole-body immersion (p = 0.01; ES 1.10, 95% CI: 0.20–1.99) but not after other therapies. No form of heat 
therapy demonstrated statistical improvements in quality of life or brachial blood pressure. Acute interventions were 
characterised by large increases in limb blood flow and core temperature, and transient reductions in blood pressure 
post-heating. At present there are only three randomised controlled trials assessing heat therapy for patients with IC. 
Moreover, each of those randomised controlled trials utilised different heat therapies. There is also very limited study 
of the acute physiological responses to different heat therapy interventions in these populations. Future research should 
establish appropriate heat therapy protocols and implement more randomised trials to understand its effectiveness. 
PROSPERO: CRD42020187941 
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Introduction 
Lower limb peripheral artery disease (PAD) is caused by the
build-up of atherosclerotic plaques in the arteries that supply
blood to the legs and feet.1 It is estimated that over 236 mil-
lion people have PAD worldwide.2 The classic symptomatic
manifestation of PAD is intermittent claudication (IC), which
is muscle pain or discomfort in the legs brought on by walk-
ing. This pain can be severely disabling and have huge
impacts on walking duration.3 Functional capacity, balance4 
and muscle strength are also frequently impaired.5 
The current clinical recommendations for first-line treat-
ment of IC include lifestyle changes, best medical therapy 
and a supervised exercise programme (SEP).6,7 Supervised 
exercise is effective in improving clinical indicators such as 
maximum walking distance and quality of life.6,8 However, 
the overall uptake, adherence9 and availability of pro-
grammes is low.10,11 In addition, some patients may not be 
able or willing to participate due to co-morbidities.12 
Therefore, alternative or adjunctive therapies may be suit-
able to help improve symptoms and functional status in 
those who are unable to regularly exercise. 
The chronic application of heat as a cardiovascular therapy
has some convincing epidemiological evidence with habitual
long-term sauna immersion being associated with substantial
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2 Vascular Medicine 00(0) 
reductions in cardiovascular and all-cause mortality.13,14 
Interestingly, the utilisation of heat therapy in patients with
PAD is not a new concept with a report in the Lancet from
1927.15 However, the interest in heat therapy for clinical popu-
lations has increased in recent years. Despite the limited results
owing to a small number of studies, there are some potentially
promising effects of heat therapy for patients with IC. A small
case-series study reported that improvements can be ascer-
tained in pain-free walking distance following a chronic heat
therapy intervention.16 In contrast, a recent randomised control
trial seemed to demonstrate no benefit in walking distance for
patients undergoing heat-therapy compared to a standard
supervised exercise programme.17 Accordingly, there is cur-
rently conflicting evidence for the effectiveness of heat ther-
apy for clinical populations.18 
Therefore, the aim of this study was to conduct a sys-
tematic review on randomised controlled trials (RCTs) 
using heat therapy for patients with PAD. We aimed to 
identify whether heat therapy is effective at improving 
walking ability and lower limb haemodynamic compared 
with a control condition. A secondary aim was to assess the 
acute physiological responses to heat therapy in order to 
better understand the mechanisms that may underpin any 
potential beneficial effects of chronic interventions. 
Methods 
This review was registered with The International
Prospective Register of Systematic Reviews
(PROSPERO) CRD42020187941 and adopted the
PRISMA guidelines for RCTs assessing heat therapy for
patients with PAD.19 
Search strategy 
Five databases (Ovid Medline / PubMed, Embase, Scopus / 
Web of Science, Cochrane Library and Health Technology 
Assessment Databases) were searched from database incep-
tion to June 2020, with an additional search in October 
2020. Only full-text articles published in English and relat-
ing to adults (over 18 years of age) were included. Titles 
and abstracts identified were independently interrogated 
for inclusion by two reviewers (AH & TC) and disagree-
ment resolved by a third reviewer (CJS). The full texts of 
any potentially eligible articles were then independently 
screened against the inclusion / exclusion criteria. The ref-
erence lists of identified studies were also hand searched 
for other relevant articles. Search terms include the follow-
ing: ‘peripheral vascular’ or ‘claudica*’ or ‘peripheral 
arter*’AND ‘heat’ OR ‘hot temperature’ OR ‘heat therapy’
OR ‘therapeutics’ OR ‘waon therapy’. 
Inclusion criteria 
We included RCTs that investigated any method of heat 
therapy in patients diagnosed with IC (Fontaine II / 
Rutherford stages 1–3). No limits were placed on the type 
of heat therapy, application of heat therapy, intervention 
frequency or duration. 
Risk of bias 
The risk of bias in each study was assessed by two inde-
pendent authors (AH & CJS) using the Cochrane 
Collaboration tool.20 This tool has three classification 
grades ‘high’, ‘low’ or ‘unclear’. Any disagreement was 
resolved by discussion with a third reviewer (TC) if 
required. 
Data extraction and management 
Data extraction was undertaken using a standardised form 
and inputted into Microsoft Excel (2010; Microsoft, 
Redmond, WA, USA). For each study we extracted infor-
mation on study characteristics, including: participants, 
sample size, inclusion/exclusion criteria, intervention com-
ponents, outcome measures and main findings. The pri-
mary outcome from chronic intervention studies were 
maximum walking distance (MWD) or maximum walking 
time (MWT) as measured by either constant or graded load 
treadmill test or the 6-minute walk distance (6MWD). 
Secondary outcomes (where reported) included: pain-free 
walking distance (PFWD) or pain-free walking time 
(PFWT), as measured by a constant or graded load tread-
mill test, ankle–brachial pressure indices (ABPI), health-
related quality of life, cardiovascular function (blood 
pressure) and physical activity levels. For acute interven-
tions, we extracted peripheral blood flow, core and skin 
temperature, blood pressure, heart rate and circulating angi-
ogenic and inflammatory signalling molecules. 
Data synthesis 
A narrative synthesis regarding participant characteristics 
and study was completed for both chronic and acute heat 
therapy interventions. Effective heat therapy interventions 
were identified as those that induce a significantly greater 
change (p < 0.05) for at least one outcome, when compared 
to a control condition. For key outcome measures (where 
reported appropriately) the mean difference (MD) between 
pre- and post-group data and between-group effect sizes 
(ES) were calculated and adjusted using Hedges bias cor-
rection for small sample sizes.21 The ES were interpreted as 
small (0.20 to < 0.50), moderate (0.5 to < 0.80) and large 
(< 0.80).20 If necessary, study authors were contacted for 
more information to allow for computation of ES. 
Results 
Included studies 
The search yielded a total of 6751 records, of which, three
RCTs and three acute interventions were included (Figure 1). 
Participants 
For chronic interventions, 73 participants were included, 
with 37 completing a heat therapy intervention. All partici-
pants were reported to have mild–moderate claudication 
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Records identified through database 
searching 


























on Additional records identified 
through other sources 
(n = 3) 
Records after duplicates removed 
(n = 6,751) 
Records screened 
(n = 6,751) 
Records excluded 
(n = 6,675) 
Full-text articles assessed 
for eligibility 
(n = 76) 
Full-text articles excluded, 
with reasons 
(n = 70) 
Not PAD (n = 30) 
No heat therapy (n = 17) 
Book chapter / review / 
letter to editor (n = 11) 
Duplicate (n =3) 
Murine (n =1) 
No access to English full
text (n =2) 
No response to request for 
text (n = 4) 
Clinical Trial record no
data generated (n = 2) 
Studies included in
qualitative synthesis 




(n = 0) 
Figure 1. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow diagram. 
PAD, peripheral artery disease. 
et al. included one patient in each group with ulcers.17 Mean 
age of included participants was 73 years and 76% were 
male. The large majority of patients included in the studies 
were hypertensive and diabetic. Medications included 
statins, aspirin, vasodilators, beta-blockers, calcium chan-
nel blockers and angiotensin-converting enzyme (ACE) 
inhibitors. Only one study specifically excluded women 
who were post-menopausal.17 
For acute interventions, 49 participants were included with
33 completing a heat therapy intervention. All participants
were reported to have mild–moderate claudication (Fontaine
IIA/IIB). Mean age of included participants was 69 years of
age, mostly male, and medications were similar to above. 
Included trials 
Three studies met the inclusion criteria for intervention 
analysis.17,22,23 Akerman et al. compared heat therapy to a 
SEP, Shinsato et al. compared heat therapy to usual care 
(best medical therapy) and Monroe et al. compared heat 
therapy to a sham treatment. None of the heat therapy treat-
ments (including duration, frequency and type) in the stud-
ies were the same (Table 1). The heat therapy treatments 
included whole-body immersion (up to shoulder height)17, 
Waon therapy (dry sauna)22 and lower-body water-perfused 
suit.23 Owing to these differences, we did not pool data for 
the purpose of a meta-analysis. 
Three acute intervention studies met the inclusion crite-
ria.24–26 Thomas et al. undertook two waist-level immersion 
sessions (active: three 3-min bouts of plantar flexion vs 
passive),26 Neff et al. used a lower-body, water-perfused 
suit (two sessions of sham and heat therapy)24 and Pellinger 
et al. undertook two lower-limb heated immersions (15 min 
vs 45 min) and one sham immersion (Table 2).25 
Risk of bias 
Risk of bias was only calculated for the chronic intervention
studies. On average, studies generally had a low risk of bias,
although some issues were identified (Figure 2). Owing to the
limited number of studies, we did not report publication bias. 
Chronic interventions 
Walking performance and clinical indicators. All three inter-
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Table 1. Summary of RCT intervention findings. 














Heat therapy vs 
usual care 
Total n = 22 (11 per group) 
Individuals with mild–moderate 
IC, resting and exercise ABPI 
< 0.8 or > 0.2 drop, diagnostic 
duplex, > 45 years old 
Exclusions: Postmenopausal (not 
on HRT); bypass graft; aorta/iliac 
disease; type 1 diabetic; previ-
ous heat intolerance; unstable 
angina, MI or IHD (past 12 
months); evidence in exercise 
test of undiagnosed IHD 
Total n = 30 (15 per group) 
Stable claudication > 6 months, 
ABPI < 0.9 
Exclusions: uncontrolled diabe-
tes, heart failure, COPD, CLI, 
ulcers; amputation; exercise-
limiting comorbidities; recent 
< 3 revascularisations or 
planned; cancer; kidney disease; 
HIV; peripheral neuropathy; 
morbid obesity 
Total n = 21 (11 in the 
intervention & 10 in control 
group) 
Minimum duration of IC = 4 
weeks, no evidence of improve-
ment despite conventional 
therapies, ABPI < 0.75, plus 
imaging confirmation 
Supervised hot immersion 3–5 ×
per week at 39°C for progressive 
duration (w1 = 20 min, w2 = 25 min, 
w3 = 30 min) to shoulder height. Fol-
lowed by 15–30 min of warm clothing 
and calisthenic exercises 
(3 × per week): seated row, bicep 
curl, calf press, chest press, lat-
eral raise, leg press, squat and tricep 
extension (room temp ~21°C). Con-
tractions last for 1 min at 16–20 RPE, 
then 1 min rest (seating / standing). 
Comparator: SEP 2 × per week (30 
min of self-paced walking and < 60 
min of self-selected circuits). Each 
exercise lasted 3 min and exercise 
intensity self-selected. Total duration 
not reported. 
Water-circulating garment that pumps 
hot water (47–50°C) round for 90 
min to increase skin temperature to 
40°C 3 × per week for 6 weeks. 
Control: Water-circulating garment 
that pumps thermoneutral water 
around leg (33°C) for 90 min 3 × per 
week for 6 weeks. 
Waon dry sauna at 60°C with no 
hydration pressure. Participants sat in 
sauna for 15 min and then underwent 
bed rest with a blanket to keep them 
warm for 30 min. Undertaken 5 ×
per week for 6 weeks. 

































tion in systolic BP 






tion in ‘Physical 
function’ (SF-36) 
(p = 0.018) and 
serum ET-1 
(p = 0.03) 
Significant improve-
ment in: 
leg pain (p < 0.05), 
6MWD (p < 0.01), 
ABPI (p < 0.01) 
No statistical com-
parison to control 
ABPI, ankle–brachial pressure index; BP, blood pressure; CD34/GAPDH, cluster of differentiation 34 / glyceraldehyde 3-phosphate dehydrogenase; 
CLI, critical limb ischemia; COPD, chronic obstructive pulmonary disease; CVC, cutaneous vascular conductance; ET-1, endothelin-1; FMD, flow 
mediated dilatation; HIV, human immune deficiency virus; HRT, hormone replacement therapy; IC, intermittent claudication; IHD, ischemic heart 
disease; MAP, mean arterial pressure; MI, myocardial infarction; 6MWD, 6-minute walk distance; NIRS, near-infrared spectroscopy; PFWD, pain-free 
walking distance; PWV, pulse wave velocity; QoL, quality of life; RCT, randomised control trial; RPE, rating of perceived exertion; SEP, supervised 
exercise programme; SF-36, Short-Form 36; VEGF, vascular endothelial growth factor. 
walking capacity. Results suggest that whole-body immer-
sion17 and Waon sauna therapy22 increased the 6MWD, 
although no statistical comparison was made to controls. 
Means difference testing demonstrated this improvement 
was significant (p = 0.03; large ES 0.94, 95% CI: 0.06– 
1.82) in Akerman et al.17 Differences were not significant 
in Shinsato et al.,22 with a moderate ES (0.77, 95% CI: 
–0.12 to 1.66) (although it crosses zero) and a non-signifi-
cant very small ES in Monroe et al. (0.16, 95% CI: –0.56 to 
0.87), again crossing zero.23 Only Akerman et al. reported a 
change in PFWD post-intervention, with a moderate ES 
(0.53, 95% CI: –0.32 to 1.39), which was not significant 
between SEP and whole-body immersion.17 
All three studies measured ABPI.17,22,23 Means difference
testing demonstrated a statistically significant improvement
in ABPI (p= 0.01; large ES 1.10, 95% CI: 0.20–1.99) favour-
ing whole-body immersion compared to SEP.17 Shinsato et al.
and Monroe et al. both had moderate ES, which were not sta-
tistically different when compared to best medical therapy
and sham treatment, respectively (ES 0.50, 95% CI: –0.37 to
1.37 and ES 0.50, 95% CI: –0.14 to 1.32).22,23 
Quality of life. Both Akerman et al. and Monroe et al. measured
and reported quality of life using the Short-Form 36 (SF-36)
tool.17,23 However, neither study reported the physical compo-
nent summary or mental component summary and only pre-
sented results for individual components. For individual
components, Monroe et al. reported a significant difference in
the ‘physical function’ component favouring heat therapy (p
= 0.018) compared to sham treatment after 6 weeks.23 Mean
difference testing demonstrated that this was not significant
with a small ES (0.25, 95% CI: –0.46 to 0.97). Akerman et al.
reported a statistical difference between whole-body immer-
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Table 2. Summary of acute intervention findings. 








Total patients with 
PAD = 11 
IIA / IIB IC; vascular 
diagnostic test; rest-
ing ABPI of < 0.7 in at 
least one leg; diagnostic 
duplex; age > 50 years 
and postmenopausal for 
females 
Total patients with 
PAD = 6 
IIA / IIB IC; resting ABPI 
of < 0.9; BMI < 35; free 
of severe walking limita-
tions due to comorbidi-
ties 
Total patients with 
PAD = 16 
Resting ABPI < 0.9 in at 
least one leg; history of 
stable IC; significant aor-
toiliac or femoropopliteal 
disease determined 
through vascular imaging 
Water immersion 
(42°C) up to the 
waist for 30 min 
Water immersion 
(40°C) up to a 
depth of 40 cm 
for 45 min 
Water-perfused 
suit up to the 
waist (48°C) for 
90 min 
Popliteal and brachial 
artery blood flow and 
shear rate (antero-
grade, retrograde and 
total) 





Popliteal artery blood 





BP and MAP 














Significant improvement in popliteal and 
brachial artery shear rate and blood flow vs 
baseline (p < 0.0001). 
SBP, DBP and MAP significantly reduced 
during HWI (p < 0.001). 
HR significantly increased during HWI 
(p < 0.001). 
PWV decreased following HWI (p < 0.01). 
HWI significantly improved lower limb 
muscle oxygenation (p < 0.05). 
Limb blood flow and 6MWD significantly 
increased after HWI (p < 0.05). 
Skin and core temperature significantly 
elevated vs control (p < 0.05). 
Marked increase in limb blood flow 
(p < 0.01) vs baseline. 
Heat therapy reduced systolic and diastolic 
BP (p < 0.05) vs control throughout the 
intervention. 
ET-1 reduced 30 min after heat therapy vs 
control. 
No change in other serum angiogenic, 
inflammatory and vasoactive mediators vs 
control. 
ABPI, ankle–brachial pressure index; BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; ET-1, endothelin-1; HR, heart rate; 
HWI, hot water immersion; IC, intermittent claudication; IL, interleukin; MAP, mean arterial pressure; MCP, monocyte chemoattractant protein-1; 
6MWD, 6-minute walk distance; NOx, nitric oxide; PWV, pulse wave velocity; SBP, systolic blood pressure; sICAM-1, soluble intercellular adhesion 
molecule-1; sTNFRII, soluble tumour necrosis factor receptor type II; sVCAM-1, soluble vascular cell adhesion molecule-1; TNF-α, tumour necrosis 
factor-alpha; VEGF, vascular endothelial growth factor. 
















































































to 1.29), although it crosses zero. 
Systemic haemodynamics. Both Akerman et al. and Monroe
et al. reported blood pressure and mean arterial pressure
responses to a heat therapy intervention.17,23 With regard to
systolic blood pressure, Akerman et al. demonstrated that
heat therapy reduced systolic blood pressure compared to
SEP (moderate ES 0.52, 95% CI: 1.37–0.33) with no effect
Akerman et al 17 
Shinsato et al 22 


















noted in Monroe et al. Diastolic blood pressure and mean
arterial pressure was also reduced in Akerman et al. (small
ES 0.41, 95% CI: –1.26 to 0.43 and moderate ES −0.59, 95%
Figure 2. Risk of bias for included randomised controlled trials. 
Symbols indicate risk level: + indicates low risk; ? and ! indicate unclear 
risk; and - indicates high risk. 
Mean difference testing demonstrated that this was not signifi-
cant with a small ES (0.24, 95% CI: –0.60 to 1.08). Role emo-
tion was significantly different (p = 0.05) between groups
CI: −1.44 to 0.26). 
Acute interventions 
Peripheral blood flow. All three acute studies included a 
measurement of popliteal flow pre and immediately post an 
acute heat therapy treatment. Results suggest that whole-
body immersion25,26 and a lower-body heated garment24 
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et al. reported that blood flow in the popliteal artery was 
increased: large ES 4.13, 95% CI: 2.13–6.14 and large ES 
1.53, 95% CI: 0.58–2.48, respectively. Neff et al. reported 
a statistically significant increase in popliteal artery blood 
flow (76%, p < 0.01); however, insufficient data were 
reported to calculate an ES. 
Core and skin temperature. Both Thomas et al. and Neff 
et al. reported core temperature responses to an acute heat 
therapy treatment.24,26 Thomas et al. demonstrated an 
increase in core temperature by 1.8°C (aural measurement) 
at the end of the session (large ES 3.40, 95% CI: 2.09– 
4.70).26 Upon cessation of the intervention, Neff et al. dem-
onstrated a significant increase in core temperature in 
comparison to the control condition (0.8°C, p < 0.01); 
however, insufficient data were reported to calculate an ES. 
Only Neff et al. reported changes in skin temperature – 
demonstrating an increase in skin temperature (~7.0°C) 
upon cessation of the heat therapy treatment (large ES 
12.81, 95% CI: 9.6–16.03).24 
Systemic haemodynamics. Both Thomas et al. and Neff et al. 
reported heart rate responses to an acute heat therapy treat-
ment.24,26 Thomas et al. and Neff et al. reported increases in 
heart rate at the cessation of a single heat therapy treatment 
(large ES 1.89, 95% CI: 0.89–2.90 and large ES 5.83, 95% 
CI: 4.24–7.42, respectively). Both Thomas et al. and Neff 
et al. reported changes in blood pressure and mean arterial 
blood pressure at the cessation of a single session of heat 
therapy. Thomas et al. demonstrated a decrease in systolic 
(large ES 1.65, 95% CI: 0.68–2.62) and diastolic blood 
pressure (large ES 1.108, 95% CI: 0.18–2.43), while mean 
arterial pressure was also reduced (large ES 1.49, 95% CI: 
0.54–2.43). Neff et al. also reported statistically significant 
decreases in systolic blood pressure (11 mmHg, p < 0.01), 
diastolic blood pressure (6 mmHg, p < 0.01) and mean 
arterial pressure (8 mmHg, p < 0.01); however, insuffi-
cient data were reported to calculate effect sizes or CIs. 
Inflammatory and angiogenic markers. Only Neff et al. 
reported changes in circulating inflammatory and angio-
genic markers. Endothelin-1 was significantly reduced (p
= 0.026) 30 minutes after cessation of heat therapy treat-
ment; unfortunately, insufficient data were reported to cal-
culate the magnitude of this effect. Further to this, Neff 
et al. reported no changes in VEGF, MCP-1, IL-1Ra, 
IL-1B, IL-6, IL-8, IL-10, TNF-α, sTNFRI, sTNFRII, 
sVCAM-1, sICAM-1 and NOx (for definitions, please refer 
to Tables 1 and 2).24 
Discussion 
The overall purpose of this systematic review was to iden-
tify whether heat therapy may be an effective therapy to 
improve walking distance and lower limb haemodynamics 
in patients with IC. The overall evidence from this review 
is limited owing to the low number of RCTs and heteroge-
neity between studies, and more studies are required before 
the efficacy of heat therapy for patients with PAD/IC can be 
clearly determined. 
Encouragingly, despite the small number of studies, our 
results indicate that there may be some benefit to heat ther-
apy; namely, whole-body water immersion and Waon ther-
apy (but not a lower-body heated garment) regarding 
6MWD. In particular, results from Akerman et al. demon-
strated a significant large ES in comparison to a routine 
SEP. This represents a mean difference of 12 metres com-
pared to a SEP and 47 metres compared to their baseline 
capacity,17 which is a large, minimal, clinically important 
difference.27 However, we note that patients in the heat 
therapy group also underwent resistance-band calisthenics-
based exercises at least three times per week, so some of the 
observed improvement could have been mediated by par-
ticipation in exercise. Nevertheless, Waon therapy also had 
a large, minimal, clinically important difference compared 
to best medical therapy, with patients increasing their 
6MWD by 81 metres.22 This is potentially an important 
clinical finding for those patients who are unable or unwill-
ing to exercise. 
The improvements in walking capacity may be mediated 
by changes in peripheral haemodynamics. Indeed, whole-
body immersion elicited a significant improvement in 
ABPI, which had a large effect size. However, this differ-
ence did not occur with the Waon therapy nor the water-
perfused garment. This is an interesting finding, as ABPI 
does not seem to increase with supervised exercise pro-
grammes.28,29 It may be that heat therapy provides a greater 
stimulus for peripheral vasodilation, generating an angio-
genic response. Indeed, Akerman et al. demonstrated sig-
nificantly increased circulating vascular endothelial growth 
factor (VEGF) following chronic heat therapy; however, 
further investigations are required.17 Conversely, Neff et al. 
did not report any increases in VEGF, nor other angiogenic 
markers during an acute heating intervention with a lower-
body heating garment.24 It remains to be seen whether 
whole-body heating, and the associated larger transient 
elevations in core temperature, induce angiogenic signal-
ling. Despite these mixed results, chronic passive heating 
interventions have been shown to induce beneficial vascu-
lar adaptations in other sedentary adults.30 Further evidence 
is required in patients with PAD to determine angiogenic 
responses following chronic heat therapy. 
Despite changes in 6MWD, none of the studies included
demonstrated statistical improvements in quality of life,
which is an important marker of disease severity in patients
with PAD.31 Furthermore, studies did not calculate the phys-
ical and mental component summary scores, which are
important distinct concepts. It may be likely that due to
small sample numbers in studies they were not powered suf-
ficiently to determine a change in quality of life. Future
studies investigating heat therapy should calculate the phys-
ical and mental component summaries and use other com-
mon questionnaires, such as VascuQoL and the Walking
Impairment Questionnaire. Furthermore, none of the
included studies measured change in walking performance
via a graded treadmill test. Graded treadmill protocols are a
common outcome measurement to assess change in walking
performance.32 They have the advantage of being conducted
in a standardised setting (i.e. grade and speed of the tread-
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good test-retest reliability.33 We would encourage future
studies to utilise both a graded treadmill protocol and a
6-minute walk test to assess changes in walking distance. 
Previous studies in other clinical populations34 and
healthy older adults35 have demonstrated a reduction in sys-
tolic blood pressure following chronic heat therapy interven-
tions. Reducing systolic and diastolic blood pressure may be
of particular importance to those with PAD, given that hyper-
tension is a major risk factor and a large proportion of
patients are on antihypertensive medication.2 Despite this, no
significant differences were reported between supervised
exercise and whole-body heating immersion, nor lower-body
water garment versus sham.17,36 However, large transient
reductions in blood pressure were demonstrated in the acute
interventions irrespective of the method of heating.24,26 
We have demonstrated that at present there is no consensus
as to the most appropriate method of heating, with each trial
included in this review using a different method and frequency
of stimulation. Accordingly, it is plausible that each respective
heat therapy method may exert positive effects via different
mechanisms. It appears at present that whole-body immersion
may provide the largest stimulus and elicit the greatest benefit,
although further research is required. Indeed, well-controlled
acute studies are required to quantify the various physiological
stimuli imposed by different methods of heating with a view to
better understanding which interventions may provide most
potential benefit when undertaken chronically. In this regard, it
is clear that limb blood flow is increased dramatically irrespec-
tive of heating method. However, it remains difficult to pro-
vide a consensus for other potentially important physiological
responses such as cardiovascular stress (i.e. increased cardiac
output) and elevations in core and muscle temperature. In
other cardiovascular populations, such as those with heart fail-
ure, evidence demonstrates improvement in left ventricular
ejection fraction and quality of life regardless of the method of
heat therapy,37 although the method of intervention is also
highly variable in the reported literature. It may also demon-
strate that those with more severe cardiovascular dysfunction
may gain greater benefits, which has considerable clinical rel-
evance, especially for those patients who are unable to tolerate
an exercise programme. 
Any intervention (or development of) should aim to be 
easy to deliver, practical and tolerable for patients. For 
example, whole-body immersion may be deliverable in the 
home-environment and could therefore ease patient burden 
to attend a centre. This could be of particular importance if 
patients are unwilling to attend a centre – in a similar man-
ner to a home-based exercise programme. Furthermore, it 
may be suited to patients who have more advanced disease 
severity and cannot exercise, acting as an alternative or 
‘gateway’ therapy. Further development of passive heating 
as an ‘alternative therapy’ should include careful considera-
tion of the factors which negatively impact uptake and 
adherence. In the context of SEPs for PAD, this appears to 
be lack of access and tolerability.10,12 Future research should 
not only focus on developing interventions which are effi-
cacious, but also those which encourage maximum uptake. 
Finally, with regard to the safety of heat therapy, in all 
trials only one adverse event was reported in association 
with heating, which was described as skin irritation.36 
However, further evidence is required to determine the 
safety of heat therapy and the risk of potential adverse 
events (such as hypotension and dizziness) both during and 
transiently following an acute bout of heat therapy. 
Limitations 
The main limitation of our review is the low number of 
studies that were available for analysis. Alongside the low 
number of studies, the maximum number of patients 
included in any of the trials was 16.36 Despite this, we still 
found significant and clinically meaningful changes in 
some parameters with moderate to large effect sizes. 
Another limitation is that the modality of heat therapy was 
different across all trials, although we note that this appears 
to be similar in other cardiovascular conditions. 
Additionally, the comparator groups differed across all 
three intervention trials, and included sham, best medical 
therapy and an exercise programme. Finally, we were also 
unable to pool results for analysis and conduct a meta-anal-
ysis, so results should be interpreted with caution. 
Conclusion 
This review demonstrated that at present there are only three
RCTs assessing heat therapy for patients with IC. Moreover,
each of those RCTs utilised different heat therapies. Only
whole-body water immersion significantly improved 6-min-
ute walk distance. The reason for the increased efficacy of
whole-body heating is currently unclear and detailed acute
studies will be required to understand the differences in
physiological stimuli which underpin subsequent chronic
adaptations. At present there appears to be some potential
benefit to heat therapy as either an alternative or an adjunc-
tive therapy for patients with IC. Future research should
endeavour to establish appropriate heat therapy immersion
protocols and implement more randomised trials in this
cohort to understand its effectiveness. 
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